Select your Market
Financial results of Q2 2024
Forecast for fiscal 2024
| Q2 2024 (in € billion) | Change (in %, compared to Q2 2023) | Organic change (in %, compared to Q2 2023) |
|---|---|---|---|
Group net sales | 5.4 | 0.9 | 1.7 |
EBITDA pre | 1.5 | ‑2.9 | ‑0.8 |
Life Science sales | 2.3 | -4.1 | -3.7 |
Healthcare sales | 2.1 | 4.3 | 5.3 |
Electronics sales | 1.0 | 6.5 | 7.6 |
“We announced that we would gradually return to organic growth during the course of 2024. The second quarter shows our progress on this journey."
Our CEO Belén Garijo comments on the Q2 2024 results.
Detailed information about the development of our business in the first half of 2024.
Downloads for the Media
Additional Downloads
Press Releases
Thanks to the good business performance of Healthcare and Electronics, Group sales in the second quarter of 2024 increased by 1.7% organically.
2024/08/01
Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more
